<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2723</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2020.121415</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>The Rate and Structure of Causes in Development of Secondary Metabolic Nephropathy in Children&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mirkhamidovich</surname><given-names>Sharipov Alisher</given-names></name></contrib><contrib contrib-type="author"><name><surname>Akmalovna</surname><given-names>Artikova Magina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Akhmatalievna</surname><given-names>Akhmatalieva Mayram</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>22</day><month>07</month><year>2020</year></pub-date><volume>4)</volume><issue/><fpage>73</fpage><lpage>76</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Metabolic disorders nephropathy (MDN) is a large group of kidney diseases with various etiologies and pathogenesis, but combined in that their development is associated with metabolic disorders that can lead to changes in the functional state of the kidneys or structural changes at the level of various structures of the nephron. Statistical variation in the registration of MDN ranges from 27% to 64% in the structure of the incidence of the urinary system in children, and in everyday practice of a pediatrician, almost every third patient has a syndrome of metabolic disorders in the urine. Establishing the nature of crystalluria as the cause of metabolic nephropathy, at what age the manifestations of MDN most often debut, the gender characteristics of this pathology, and finally, the determination of the genealogical relationship is a widely discussed focus of research on this field. Therefore, our results showed that oxalate-calcium crystalluria accounted for the majority of cases of crystalluria, especially from 6 months to 7 years of age, which predetermined the majority of cases of secondary oxalate nephropathy, especially in boys who had a longer course of oxaluria. Genealogical analysis of anamnestic data reflected the high incidence of kidney stones diseases and dysuric syndrome, which correlated with a hereditary burden in the gastrointestinal tract, among parents and immediate relatives of the studied children with SMN.&#13;
</p></abstract><kwd-group><kwd>Metabolic disorders nephropathy</kwd><kwd> Secondary oxalate nephropathy</kwd><kwd> Crystalluria</kwd><kwd> Oxalate-calcium crystalluria.</kwd></kwd-group></article-meta></front></article>
